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Abstract  
Aflatoxins and fumonisins are referred to as Mycotoxins. They are secondary metabolites of some moulds which 
are highly toxic, mutagenic or teratogenic compounds. These substances are not formed by all mould species but 
are characteristic of their producers. The aim of this study was to determine the occurrence of Aflatoxin and 
Fumonisins contamination in herbal medicinal products sold in Nairobi Kenya. The study was undertaken in 
Nairobi, the capital and largest city in Kenya. Nairobi has several herbal clinics, especially in densely populated 
areas. This study employed an exploratory as well as laboratory-based experimental design to sample 138 herbal 
medicinal products. The sample were in different preparations, which included liquids, powders, capsules, 
creams/lotions, and syrups. Screening of the presence of aflatoxins and fumonisins were done using Envirologix 
Quick ToxTM Kit following the manufacturer’s instructions. Fumonisins and aflatoxins concentration in parts per 
billion (ppb) was analyzed statistically using Pearson Chi square test at 95% confidence interval. Contaminations 
were presented in form of frequencies and percentages. Aflatoxins were detected in 74(53.6%) samples while 
fumonisins were detected in 75(54.3%). Four (11.8%) samples from herbal clinics and 3(4.1%) from street 
vendors in form of powders and liquids had aflatoxins levels above 4.0ppb. Nine (26.5%) samples from herbal 
clinics, 10(13.5%) from streets vendors/hawkers and two (10.5%) from the supermarkets in form of powders and 
liquids had fumonisins levels above 4.0ppb. There was no significant association (χ2 test; p>0.05) between 
detection of fungi from an herbal product and the occurrence of mycotoxins. Aspergillus flavus and A. parasiticus 
isolated in this study were associated with occurrence of aflatoxins while the Fusarium isolated were responsible 
for the presence of fumonisins among the herbal products. We conclude that herbal products investigated were 
contaminated with fumonisins and aflatoxins in varying degrees. Some were contaminated beyond the accepted 
limits. There were many genera of molds isolated in this study, which are associated with mycotoxins 
production, but the current study only focused on aflatoxins and fumonisins and therefore other mycotoxins 
should be investigated so as to ensure overall fungi toxins safety among the herbal products. 
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1. Introduction 
Aflatoxins and fumonisins are referred as Mycotoxins. They are secondary metabolites of some moulds which 
are highly toxic, mutagenic or teratogenic compounds. These substances are not formed by all mould species but 
are characteristic of their producers.  The occurrence of toxigenic mycoflora and mycotoxins in medicinal plants 
and herbal products has been reported by Alwakeel, (2009). Aspergillus, Penicillium and Fusarium are the major 
genera reported to produce mycotoxins (Rodriguez-Amaya and Sabino, 2002). Several environmental factors are 
reported to influence mycotoxin production, but temperature and humidity are considered to be the most critical 
(Simsek et al., 2002).  
 
Aflatoxins are secondary metabolites produced by various species of the genus Aspergillus which includes A. 
flavus and A. parasiticus. Sometimes the fungus is damaged by adverse conditions especially during processing 
of the products. However aflatoxins are not affected by processing because they are heat stable.  The stability of 
aflatoxins during food processing is affected by many factors, including: the moisture of the product, the toxin 
concentration and its location and the presence of additives. These factors should therefore be considered with 
respect to each type of processing (e.g. milling, roasting, canning, oil extraction) when estimating the fate of the 
mycotoxin (Ezekwesili-Ofili et al., 2014).  
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The prevalence of Fusarium and the subsequent production of fumonisins are enhanced by warm climates and 
under drought conditions, factors that cannot be controlled, although growers and consumers should be made 
aware that high concentrations of fumonisins are to be expected under such conditions (Dragan et al., 2001). 
Insect damage also affects the accumulation of fumonisins, and both the prevalence and degree of insect damage 
are significantly correlated with the concentrations of the toxins (Korir et al., 2017). The safe moisture content 
for natural product is 14–15%. Although mycotoxin contamination of foods and feed has been a worldwide 
problem as demonstrated by an estimate from the Food and Agriculture Organization (FAO) of the United 
Nations, recent focus has however been on contamination of medicinal herbal products (Simsek et al., 2002). In 
the present study; we evaluated selected herbal medicinal products (HMPs) from Nairobi, Kenya, for the 
presence of aflatoxins and fumonisins contaminations and compared them with European pharmacopeia 
specifications. 
 
2. Materials and methods  
2.1 Study site and design  
The study was undertaken in Nairobi, the capital and largest city in Kenya. Nairobi has several herbal clinics, 
especially in densely populated areas. However HMPs are also sold in nutrition stores, pharmacies/chemists, 
supermarkets, local retailers, and hawkers, among other outlets. This study employed an exploratory as well as 
laboratory-based experimental design.  
 
2.2 Sample collection 
We collected HMPs from different herbal vendors across Nairobi City in Kenya. The study sample included 138 
different HMPs in different preparations, which included liquids, powders, capsules, creams/lotions, and syrups.  
 
2.3 Determination of aflatoxins and fumonisins 
Screening of the presence of aflatoxins and fumonisins were done using Envirologix Quick ToxTM Kit following 
the manufacturer’s instructions. Briefly, the toxins were extracted from the sample with 70% methanol and 
shaken for 2 minutes and incubated for five minutes. Exactly 100 µl of the top layer were drawn and dispensed 
into a small vial and then mixed with 100µl buffer and mixed well before applying the strip and incubated for 
five minutes. The two lines in the rapid strip indicate a positive test while one line indicates a negative test. The 
strips were placed in a Quick Scan Machine-reader and the machine reads the concentrations of the toxins and 
displays the results on a computer screen in parts per billion (ppb). Two standards with 0.0025 ppb levels of 
aflatoxins and 0.004ppb of fumonisins were included in the analysis for quality control purposes.  
 
2.4 Data analysis 
We used Statistic Package for Social Scientist (SPSS) for statistical analysis (SPSS version 20) in this study. 
Fumonisins and aflatoxins concentration in parts per billion (ppb) was analysed statistically using Pearson Chi 
square test. Contamination was presented in form of frequencies and percentages. A significance level of 0.05 
which is 95% confidence interval was used for all the tests. 
 
3. Results  
We collected and analysed 138 samples of HMPs. These samples included 106 powders (76.8%), 18 liquids 
(13.0%), 8 syrups (5.8%), 4 creams/lotions (2.9%), and 2 capsules (1.4%). Seventy-four of the samples (53.6%) 
came from street vendors/hawkers, 34 (24.6%) from herbal clinics, 19(13.8%) from supermarkets/shops, 
7(5.1%) from manufacturers/wholesalers, and 2 each (1.4%) from chemists and health food stores, respectively. 
 
3.1Determination of aflatoxins from the herbal products 
The herbal products were contaminated with aflatoxin to varying degrees. They were detected in 74(53.6%) 
samples while in 64(46.4%) samples, their levels were below the limit of detection (Table 1). All the samples 
from the chemist had aflatoxin levels below the limit of detection (<LOD). Among the aflatoxins contaminated 
samples 67(48.6%) had aflatoxin contamination range from 0.001-4.00ppb. Only 7(5.1%) samples had aflatoxins 
levels above 4.0ppb. These samples were; 4(11.8%) from herbal clinics and 3(4.1%) from street vendors.  The 
general safety limits for total mycotoxins in herbal products should not exceed 4 ppb which is equivalent to 
4µg/g. Data analysis showed that there was significant association between samples from herbal clinics and 
street vendors with aflatoxins contaminations (χ2 test; p=0.001). 
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Table 2 shows that, 1(6.3%) liquid and six (5.8%) powders had aflatoxins levels above 4.0ppb. Seven (43.8%) 
liquids, 2(66.7%) creams/lotion, 48(45.2%) powders and 7(87.5%) syrups had aflatoxins levels below the limit 
of detection. Some samples had aflatoxins ranging from 0.001-4.00ppb.  There was significant association 
between samples formulated in terms of powders and liquids with aflatoxins contaminations (χ2 test; p=0.001) as 
shown in Table 2. 
 
3.2 Relationship between fungi and aflatoxins 
Table 3 showed that, 44(59.5%) samples which were not contaminated with fungi were positive for aflatoxins. 
Thirty four (53.1%) fungal contaminated samples were also positive for  aflatoxins. There was no significant 
association bewteen the presence of fungi and aflatoxins contamination among the herbal products (χ2 test; 
p=0.779).  
 
3.4 Determination of fumonisins from the herbal products 
Sixty-four (46.4%) samples had fumonisins levels below the limits of detection. All samples from health food 
stores, 16(47.1%) from herbal clinics, 3(42.9%) from manufacturers/wholesalers, 26(35.1%) from street 
vendors/hawkers and six (31.6%) from supermarkets had fumonisins ranging from 0.001-4.0ppb. Nine (26.5%) 
samples from herbal clinics, 10(13.5%) from streets vendors/hawkers and two (10.5%) from the supermarkets 
had fumonisins levels above 4.0ppb. Data analysis showed that there was significant associations among samples 
from herbal clinics, street vendors/hawkers and supermarkets/shops (χ2 test; p=0.001) with fumonisins 
contaminations (Table 4). 
 
Table 5 shows that, 2(100.0%) capsules, 5(31.3%) liquids, 43(41.3%) powders and one cream/lotion, juice and 
syrups, respectively had fumonisins contamination ranging from 0.001-4.0ppb. Two (12.5%) liquids and 
19(17.3%) powders had fumonisins levels above 4.0ppb. There was significant association between liquids and 
powders formulations with aflatoxins contaminations (χ2 test; p=0.001). 
 
3.5 Relationship between fungi and fumonisin 
Table 6 shows that, 36(47.4%) samples were not contaminated with fungi yet they were positive for  fumonisins 
contamination. Thirty eight (62.3%) samples were contaminated with fungi and positive for  fumonisins. There 
was no significant association between fungal contamination and the presence of  fumonisins (χ2 test; p=0.081).  
 
4. Discussions  
Aflatoxin contaminations were determined among the sampled products in this study. The results showed that 
the herbal products were contaminated with aflatoxins to varying degrees. The general safety limits for total 
mycotoxins in herbal products should not exceed 4 ppb (µg/kg) according to European Pharmacopoeia (2007). 
Most (53.6%) samples were contaminated with aflatoxins although a few (5.16%) had aflatoxins levels beyond 
4ppb hence were not safe for human consumptions. Four (11.8%) samples from herbal clinics and three (4.1%) 
from street vendors had aflatoxins levels above 4.0ppb.  These samples from herbal clinics and street 
vendors/hawkers were contaminated with aflatoxins levels above the accepted limits. These contaminated 
samples were in form of powders and liquids formulations. Aflatoxins are secondary metabolites of some 
moulds, which include highly toxic, mutagenic or teratogenic compounds (Simsek et al., 2002).  
 
Aflatoxins were detected in 59.5% of the samples and yet they were free from fungi contamination while some 
(53.1%) of fungi contaminated samples had aflatoxins. In this case, aflatoxins were not detected in all the fungi 
contaminated samples likewise to the samples which were free from fungi contamination, aflatoxins were 
detected in some. For the samples free from fungi yet aflatoxins were detected could be because fungi were 
destroyed during herbal products processing. The study found that there was no significant association between 
(p<0.05) the presence of fungi and aflatoxins contamination. The occurrence of aflatoxins and other mycotoxins 
in herbal medicines as observed in the present study has been reported previously (Kneifel et al., 2005; Sewaram 
et al., 2006; Pavlovic et al., 2006; Alwakeel, 2008). The mycotoxins pose great concern over consumer safety. 
Adriana et al., (2006) in a study on fungal contamination of herbal products found that 49% of the isolates 
produced high levels of aflatoxins.  Alwakeel, (2009) in a similar study reported the occurrence of toxigenic 
mycoflora and mycotoxins in medicinal plants and herbal products. The effects of mycotoxins especially 
aflatoxins on various organs have been reported in both experimental animals and man (Alwakeel, 2009). 
Impaired liver, kidney and brain function are well known consequences of ingesting even minute quantities of 
aflatoxins. Some studies claim that exposure to high levels of aflatoxins can lead to neurological problems and in 
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some cases may lead to death (Kneifel et al., 2002; Sewaram et al., 2006; Pavlovic et al., 2006; Alwakeel, 2008). 
Since they are generally regarded as indestructible in all contaminated consumable items, they cannot be 
removed or destroyed, so prevention is the only real way forward. Aflatoxins are both hepatotoxic and 
hepatocarcinogenic (Orsi et al, 2007). Prolonged exposure, (especially daily home exposure), may be 
particularly harmful (Ezekwesili-Ofili et al., 2014). 
 
Although not all fungi produce aflatoxins, Aspergillus flavus and A. parasiticus are the two major genera reported 
to produce toxigenic aflatoxins according to Riba et al., (2008).  Aspergillus flavus and A. parasiticus have been 
reported to have the ability to produce aflatoxins in other previous studies (Tassaneeyakul et al., 2004; Korir and 
Bii, 2012). Samples in the current study were contaminated with saprophytic fungi, pathogenic/mycotoxin 
producing fungi as well as pathogenic yeasts. Several environmental factors are reported to influence aflatoxins 
production, but temperature and humidity are considered to be the most critical according to a study by Simsek 
et al., (2002). The prevalent weather conditions of Nairobi City where the herbal products were sampled from, 
are a predisposing factor for fungal growth which eventually produce aflatoxins and other mycotoxins as 
secondary metabolites.  
 
Fumonisins are mycotoxins produced by fungi of the genus Fusarium. Fusarium oxysporum, Fusarium 
moliniform, Fusarium solani and Fusarium spp were isolated in this study and are associated with fumonisins 
contamination among the samples. Samples had fumonisins levels in varying degrees. Twenty one samples had 
fumonisins levels above 4.0ppm hence beyond accepted limits. Nine samples from herbal clinics, ten from 
streets vendors/hawkers and two from the supermarkets had fumonisins levels above 4.0ppb. These products 
were in form of liquids and powders. The presence of Fumonisins and fungal contamination among the samples 
showed that 47.4% of the samples were free from fungal contamination yet they had fumonisins contamination. 
Some (62.3%) were contaminated with both fungi and Fumonisins. Statistical analysis revealed that  there was 
no significant association (χ2 test; p=0.081) between fumonisin detection and fungal contamination among the 
samples interms of sources/formulations. 
 
In both liver and kidney, fumonisin B-induced toxicity is often characterized; initially by increased apoptotic and 
oncotic necrosis, regeneration and in the case of liver, bile-duct hyperplasia (Bhandari et al., 2001). 
Experimental evidence for synergistic interactions between aflatoxin B1 and fumonisin B1 (Gelderblom et al., 
1999; WHO, 2000a; Carlson et al., 2001) and between aflatoxin B1 and nivalenol (Ueno et al., 1992; Cohen et 
al., 2000) in inducing hepatic cancer in rats has been reported. According to WHO (2000b) an association has 
been established between the occurrence of the Fusarium verticillioides, Fusarium moniliforme and other 
Fusarium mycotoxins on maize and the incidence of oesophageal cancer in various regions of the world. In this 
study, Fusarium producing mycotoxins were detected hence, the products are not safe for human consumption to 
some degree.  
 
5. Conclusion  
Samples were contaminated with Fumonisins and Aflatoxins at varying degrees. Among the samples, 15.2% 
were contaminated with fumonisins beyond the accepted European Pharmacopoeia accepted limits while 5.2% 
had aflatoxins levels beyond this limits (4ppb) hence were not safe for human consumptions. Herbs from street 
vendors and herbal clinics, which were in form of powders and liquids, were highly contaminated (beyond 
4.0ppb). There was no significant association between the presence of fungi and aflatoxins/fumonisin 
contamination among the herbal product (χ2 test; p=0.779 and χ2 test; p=0.081, respectively).  
 
6. Recommendation  
There were varieties of molds isolated in this study, which are associated with mycotoxins production, the 
current study only focused on aflatoxins and fumonisins and therefore other mycotoxins should be investigated 
so as to ensure overall fungi toxins safety among the herbal products. 
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List of Tables  
 
Table 1: Association between aflatoxin contamination and source of herbal products 
Source  Aflatoxin Contamination Level (ppb) n/Freq χ2 
 <LOD 0.001-4.0 >4.000   
Chemist 2(100.0%) 0(0.0%) 0(0.0%) 2  
Health Food Store 0(0.0%) 2(100.0%) 0(0.0%) 2  
Herbal Clinic 8(23.5%) 22(64.7%) 4(11.8%) 34 0.001 
Manufacturer/ Wholesaler 5(71.4%) 2(28.6%) 0(0.0%) 7 1.000 
Street vendor/ Hawker 37(50.0%) 34(45.9%) 3(4.1%) 74 0.001 
Supermarket/ Shop 12(63.2%) 7(36.8%) 0(0.0%) 19 1.000 
Total  64(46.4%) 67(48.6%) 7(5.1%) 138  
Key: LOD-Limit of detection, 0.001-4.00-fumonisin range, >4.000- fumonisin more than 4.0ppb, n-Number of 
samples per category, χ2 - Chi square test  
  
Table 2: Association between aflatoxin contamination and type of herbal formulation 
Formulations Aflatoxins Contamination Level (ppb) n/Freq χ2 
Capsules 0(0.0%) 2(100.0%) 0(0.0%) 2  
Liquid 7(43.8%0 8(50.0%) 1(6.3%) 16 0.001 
Cream/lotion 2(66.7%) 2(33.3%) 0(0.0%) 3 .100 
Juice 0(0.0%) 2(100.0%) 0(0.0%) 2  
Powder 48(45.2%) 52(49.0%) 6(5.8%) 106 0.00 
Syrup 7(87.5%) 1(12.5%) 0(0.0%) 8 1.001 
Total  64(46.4%) 67(48.6%) 7(5.1%) 138  
Key: LOD-Limit of detection, 0.001-4.00-fumonisin range, >4.000- fumonisin more than 4.0ppb, n-Number of 
samples per category, χ2 - Chi square test  
 
Table 3: Association between fungal contamination and aflatoxins  
Samples  Aflatoxins Detection Statistics  
Contamination >LOD (n) (%) With toxins (n) 
(%) 
Total (n) (%) χ2 df p 
No Fungi 30 (40.5) 44 (59.5) 74 (100.0) 0.078 1 0.779 
With Fungi 30 (46.9) 34 (53.1) 64 (100.0) 
Total 60 (43.5) 78 (56.5) 138 (100.0) 
Key: χ2 - Pearson Chi-square Value, df – Degree of freedom, p-value, ppb-parts per billion, (n)-frequency, (%) - 
percentage 
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Table 4: Fumonisins contamination of herbal product   
Sources & formulations  Fumonisin Contamination Levels (ppb) n/Freq χ2 
 <LOD 0.001-4.000 >4.000   
Chemist 2(100.0%) 0(0.0%) 0(0.0%) 2  
Health Food Store 0(0.0%) 2(100.0%) 0(0.0%) 2  
Herbal Clinic 9(26.5%) 16(47.1%) 9(26.5%) 34 0.001 
Manufacturer/ Wholeseller 4(57.1%) 3(42.9%) 0(0.0%) 7 1.000 
Street vendor/ Hawker 38(51.4%) 26(35.1%) 10(13.5%) 74 0.001 
Supermarket/ Shop 11(57.9%) 6(31.6%) 2(10.5%) 19 0.001 
Total  64(46.4%) 53(38.4%) 21(15.2%) 138  
Key: LOD-Limit of detection, 0.001-4.00-fumonisin range, >4.000- fumonisin more than 4.0ppb, n-Number of 
samples per category, χ2 - Chi square test 
 
Table 5: Fumonisins contamination of herbal product   
Formulations  Fumonisin Contamination Levels (ppb) n/Freq χ2 
Capsules 0(0.0%) 2(100.0%) 0(0.0%) 2  
Liquid 9(56.3%) 5(31.3%) 2(12.5%) 16 0.001 
Cream/lotion 2(66.7%) 1(33.3%) 0(0.0%) 3 .100 
Juice 1(50.0%) 1(50.0%) 0(0.0%) 2  
Powder 44(41.3%) 43(41.3%) 19(17.3%) 106 0.001 
Syrup 7(87.5%) 1(12.5%) 0(0.0%) 8 1.000 
Total  64(46.4%) 53(38.4%) 21(15.2%) 138  
Key: LOD-Limit of detection, 0.001-4.00-fumonisin range, >4.000- fumonisin more than 4.0ppb, n-Number of 
samples per category, χ2 - Chi square test 
 
Table 6: Relationship between fungi and fumonisin 
Samples Fumonisins Statistics  
Fungal 
Contamination 
LOD (n) (%) Detected 
(n) (%) 
Total (n) (%) χ2 df p 
Not contaminated 38 (52.6) 38 (47.4) 76 (100.0) 3.035 1 0.081 
Contaminated 23 (37.7) 39 (62.3) 62 (100.0) 
Total 61 (46.0) 77 (54.0) 138 (100.0) 
Key: χ2 - Pearson Chi-square Value, df – Degree of freedom, p-value, ppb-parts per billion, (n)-frequency, (%) - 
percentage 
 
 
